Ibex Biosciences
Biopharmaceutical company.
Based in MD
AI Overview
With $280K in lobbying spend across 9 quarterly filings, Ibex Biosciences is an active lobbying client. Their lobbying covers 4 issue areas. Active from 2023 to 2024.
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2023 | $180K |
| 2024 | $100K |
Issues Lobbied
Lobbying Firms
Lobbyists
Government Agencies Targeted
These are the government entities that Ibex Biosciences disclosed contacting in their lobbying filings.
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Budget/Appropriations, Education, Foreign Relations, MED
Advocacy related to the development of therapies for various medical issues, particularly for the treatment of Malaria. Advocacy in support of federal funding for a GMP Facility related to biopharmace
Advocacy in support of federal funding for a GMP Facility related to biopharmaceutical development.
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.